ARTICLE | Clinical News
Lenvatinib: Preliminary Phase II data
February 9, 2015 8:00 AM UTC
Preliminary data from the Phase II portion of the open-label, international Phase Ib/II Study 205 in 153 patients with unresectable, advanced or metastatic RCC following 1 prior VEGF-targeted treatmen...